A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 5,000
- 试验地点
- 1
- 主要终点
- Number of hospitalizations for acute heart failure (HF)
研究概览
简要总结
The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.
详细描述
The purpose of this study is to discover biomarkers for early identification, diagnosis, molecular classification, and intervention based on the mechanism of ischemic heart disease（IHD）. Using mass spectrometry-based metabolomics and multimodal imaging technology, the study aims to further construct a new system for early risk stratification of IHD based on abnormal metabolites.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- •Current known inability to follow instructions or comply with follow-up procedures.
- •Eligible patients without informed consent form
结局指标
主要结局
Number of hospitalizations for acute heart failure (HF)
时间窗: These data is collected during follow-up visit at 3/6/12/24/36/48 months after discharge
Unplanned emergency visits or hospitalizations leading to HF deterioration were defined as hospitalizations for HF
次要结局
- Number of major adverse cardiovascular events (MACE)(These data is collected during follow-up visit at 3/6/12/24/36/48 months after discharge)